ArticlebioRxiv : the preprint server for biology2023
Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1.
Ling He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.